The visit of American physician and PRF technology specialist James Waite to NOVO Medical Center is a significant event for medical professionals, offering an opportunity to gain new knowledge and explore ways to apply cutting-edge techniques in Ukrainian medicine.
On September 12, as part of the NOVO Study Club educational programs, a lecture by the invited expert took place, during which Dr. Waite, using interactive technologies, shared valuable experience about the PRF method, which has gained popularity worldwide over the past 6-7 years.
PRF, or Platelet-Rich Fibrin, is produced from whole blood without the addition of anticoagulants. It must be centrifuged for 90 seconds after collection, before it begins to clot, to obtain a solid clot or liquid form.
Before the event, James Waite visited NOVO Medical Center, where he familiarized himself with the latest MRI, CT, ultrasound, and endoscopic technologies used at the facility, which enable the Center’s specialists to conduct highly accurate examinations and provide patients with comprehensive diagnostic results.
The Medical Director of NOVO, Anzhela Dyba, informed the distinguished guest about the specifics of the Center’s operations, advanced treatment technologies, plans, prospects, and NOVO’s capabilities in implementing projects.
In turn, the Director of NOVO Medical Center, Taras Lysak, told James Waite about the Center’s charitable programs for socially vulnerable groups—children and adults—which the Center has been implementing for nearly 11 years, with an especially urgent need felt since the full-scale invasion of our country by the aggressor nation.
During the lecture, Dr. Waite focused the attention of medical professionals on key aspects of his work in the USA:
- Active factors in PRF and PRP technologies, their main effects, and significant differences between the methods;
- Forms of PRF and methods of obtaining them;
- Innovativeness of horizontal centrifugation;
- Types of tubes used in PRF technologies;
- Analytics regarding clot formation based on gender, age, geographic factors, and more.
Due to the fact that the effect of PRF therapy lasts 10-14 days, compared to about two days for PRP, cells and factors remain highly concentrated thanks to the centrifugation process and are recruited throughout the time the clot is active.
Solid clots can be pressed into membranes, cut into individual shapes, divided into parts, and mixed with bone fragments, placed under incisions, used to fill defects or tooth extraction sites with or without added bone.
Liquid PRF can be injected along incisions, administered via injection or microneedling for facial rejuvenation and even hair regrowth, injected into joints or other tissues, added to bone grafts, and allowed to clot to improve the efficiency and characteristics of implant processing.
